Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance.
about
Phase II study of immunomodulation with granulocyte-macrophage colony-stimulating factor, interleukin-2, and rituximab following autologous stem cell transplant in patients with relapsed or refractory lymphomas.Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells.A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.Prevention of acute graft-versus-host disease by magnetic nanoparticles of Fe₃O₄ combined with cyclosporin A in murine models.Concise review: acute graft-versus-host disease: immunobiology, prevention, and treatment.Harnessing autophagy for cell fate control gene therapyAutologous hematopoietic stem cell transplantation in autoimmune diseases.Acute graft-versus-host disease following hematopoietic stem-cell transplantation.Engraftment syndrome: double-edged sword of hematopoietic cell transplants.Immunotoxicologic effects of cyclosporine on tumor progression in models of squamous cell carcinoma and B-cell lymphoma in C3H mice.T-cell subsets in autologous and allogeneic peripheral blood stem cell concentrates.Skin Graft-versus-host Disease Following Autologous Stem Cell Transplantation for Multiple Myeloma.Mechanical characterization of adult stem cells from bone marrow and perivascular niches.Pulmonary graft-versus-host disease after autologous hematopoietic stem cell transplantationAutograft immune effector cells and survival in autologous peripheral blood hematopoietic stem cell transplantation.Immunophenotypic and molecular comparison between allogeneic and autologous graft-vs-host disease of the skin: A retrospective study using immunohistochemical and proteomics methods.Autologous GVHD?
P2860
Q33389752-3C73CBCD-8867-4097-B69A-EDDDCDBD135BQ33748026-6FCD5CDA-6D32-4351-B626-B20810DE2CDFQ34089567-DDAB5370-A124-42A3-9109-719224D82B17Q35547222-D65A9590-D787-4E3C-BBF0-6E0B1B02B677Q36861714-1F7BC9E4-97EA-4FB6-99FE-4E7BCEE6C3B9Q37043025-A64EFAD9-1333-4138-B858-3C3B6DBA65D3Q37810087-46D23370-C5AE-4474-A768-46EEE8D78290Q37930715-1524FB58-46FC-4BC1-B1A9-328860826E8AQ38315390-8415D58D-D5D7-4845-ABF9-B58F4B322D87Q39402703-F4216106-A906-459B-9864-F1C1F5B0153BQ40871937-94F1CEAB-59FE-4239-ACEB-FABA9EEBF428Q41786143-E146FE55-3AB3-438A-9F3F-0D5A328045F0Q42009996-F1488537-7C75-42C6-B9B2-15C017D0E6F7Q42374523-33077419-7867-4F58-86E6-FCFF4733816BQ47258187-D74A80E2-6891-4A3D-8562-E61D551CC9C8Q48347965-580997C6-4B1E-4C3B-87F4-FC0BD72D36C3Q53029825-26C9F716-E3D9-4406-82CD-92B6C89168DF
P2860
Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Autologous graft-versus-host d ...... rough impaired self-tolerance.
@en
Autologous graft-versus-host d ...... rough impaired self-tolerance.
@nl
type
label
Autologous graft-versus-host d ...... rough impaired self-tolerance.
@en
Autologous graft-versus-host d ...... rough impaired self-tolerance.
@nl
prefLabel
Autologous graft-versus-host d ...... rough impaired self-tolerance.
@en
Autologous graft-versus-host d ...... rough impaired self-tolerance.
@nl
P2093
P2860
P356
P1476
Autologous graft-versus-host d ...... hrough impaired self-tolerance
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BMT.1705931
P407
P577
2007-11-19T00:00:00Z